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Abstract
Background
Adherence to antiretroviral therapy (ART) and long-term uninterrupted engagement in HIV
care is difficult for HIV-positive people, and randomized trials of specific techniques to pro-
mote adherence often show small or negligible effects. Understanding what influences deci-
sion-making in HIV-positive people in Africa may help researchers and policy makers in the
development of broader, more effective interventions and policies.
Methods
We used thematic synthesis and a grounded theory approach to generate a detailed narra-
tive and theoretical model reflecting life with HIV in Africa, and how this influences ART
adherence and engagement decisions. We included qualitative primary studies that
explored perspectives, perceptions and experiences of HIV-positive people, caregivers and
healthcare service providers. We searched databases from 1 January 2013 to 9 December
2016, screened all studies, and selected those for inclusion using purposeful sampling
methods. Included studies were coded with Atlas.ti, and we assessed methodological qual-
ity across five domains.
Results
We included 59 studies from Africa in the synthesis. Nine themes emerged which we
grouped under three main headings. First, people who are HIV-positive live in a complicated
world where they must navigate the challenges presented by poverty, competing priorities,
unpredictable life events, social identity, gender norms, stigma, and medical pluralism—
these influences can make initiating and maintaining ART difficult. Second, the health sys-
tem is generally seen as punishing and uninviting and this can drive HIV-positive people out
of care. Third, long-term engagement and adherence requires adaptation and incorporation
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of ART into daily life, a process which is facilitated by: inherent self-efficacy, social responsi-
bilities, previous HIV-related illnesses and emotional, practical or financial support. These
factors together can lead to a “tipping point”, a point in time when patients choose to either
engage or disengage from care. HIV-positive people may cycle in and out of these care
states in response to fluctuations in influences over time.
Conclusion
This analysis provides a practical theory, arising from thematic synthesis of research, to
help understand the dynamics of adherence to ART and engagement in HIV care. This can
contribute to the design of service delivery approaches, and informed thinking and action on
the part of policy makers, providers, and society: to understand what it is to be HIV-positive
in Africa and how attitudes and the health service need to shift to help those with HIV lead
‘normal’ lives.
Introduction
Initiating and maintaining HIV-positive people on antiretroviral therapy (ART) over the long
course of HIV infection represents a growing challenge, as initiatives such ‘test and treat’ [1]
and ‘rapid-ART’ initiation [2] expand ART provision globally. Africa carries the largest burden
of HIV infections, with approximately 26 million HIV-positive people living in the region, and
just over 50% of these accessing ART in 2017 [3]. Reports suggest that—among those on ART—
retention in care [4] and viral suppression continues to lag behind targets [5] and this has led to
substantial investments in interventions to improve retention and adherence [6]. Meta-analyses
demonstrate that single interventions such as mobile phone reminders have modest effects on
improving adherence to ART, that there is marked heterogeneity of effectiveness across trials,
that effects may wane over time, and that even community-based initiatives show little impact
overall [7–9]. Several ‘patient-centered’ interventions are currently being developed and imple-
mented [6], however few offer highly effective solutions, particularly for vulnerable groups such
as women and children, key populations, men, and young adults.
The lack of effectiveness of adherence and retention interventions has led to a shift from a
technocratic approach to sociopolitical resulting in a proliferation of studies evaluating barri-
ers and facilitators to ART adherence and engagement in care. The current literature however
does not clearly reflect the pervasive set of challenges that HIV-positive people face, the inter-
dependence of all these influences and how these impact on the HIV care cascade. Our evalua-
tion of published systematic reviews on barriers and facilitators to ART adherence and
engagement identified that many syntheses are either outdated, focused on specific sub-popu-
lations, generate simplified lists of barriers and facilitators, or evaluate primarily individual
components of the HIV care cascade, such as linkage or retention [10–26]. And, although
there are several existing health behavior theories which can be applied to HIV care [27, 28],
many these, including the Information, Motivation, Behavioral Skills Model, Theories of Rea-
soned Action and Planned Behavior, the Transtheoretical Model, and Social Cognitive Theory
focus primarily on an individual’s ability to perform a health behavior with comparatively little
focus on the role of society and the environment. Frameworks such as the social ecological
framework [28, 29] and the behavior change wheel proposed Michie et al [30], incorporate the
role of society and the environment at a greater level, and are useful for categorizing and
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mapping barriers and facilitators directly to interventions, but do not capture the dynamic
nature of influences and how these change over time for individuals.
We used thematic synthesis and a grounded theory approach to conduct a systematic
review and meta-synthesis of qualitative research conducted across Africa and present a broad
perspective of the fundamental drivers of ART adherence and engagement behaviors, with the
intention of generating a generalizable theory to help practitioners, policy makers and
researchers consider what influences may impact on responses to HIV care at all levels of the
cascade. Our aim is to inform an understanding of ‘why people do what they do’ and assist
with future development of truly patient-centered health services and policies for HIV-positive
people in Africa.
Methods
We defined our methods in advance with a protocol agreed between authors [31], differences
between the protocol and final methods are detailed in S1 Appendix.
Criteria for considering studies for inclusion
We considered qualitative studies that used ethnographies, process evaluations, case studies,
and mixed-methods and used data collection techniques including observations, interviews,
focus groups, and document analyses to collect qualitative data; and thematic analyses, narra-
tive analyses, and presentations of findings to analyze qualitative data. Studies that used quali-
tative data collection methods but not qualitative data analysis methods were ineligible. We
restricted studies to those conducted in low-and-middle-income countries (LMICs). We
included studies that explored our phenomenon of interest, specifically—perspectives, percep-
tions, and experiences of HIV-positive people, caregivers, and providers that influenced link-
age, retention, and adherence to ART. We included studies with participants who were: HIV-
positive children, adolescents and adults, healthcare workers, traditional healers who provided
services to HIV-positive people, and caregivers of HIV-positive people. We excluded studies
conducted in women receiving short-term ART prophylaxis solely for prevention of mother to
child transmission and not for their own health.
Search methods for identifying studies
We searched Medline, Embase, CINAHL, PsychInfo, LILACS, Global Health Library (date of
last search 4 December 2016) and the Proquest Dissertation and Thesis database (9 December
2016). We limited our search to studies published from 1 January 2013 to include the most
recent literature. Our search strategy included terms related to HIV, retention in care, adher-
ence, linkage, LMICs and qualitative data collection and analysis methods. The full search
strategies for each database are reported in S2 Appendix.
Selection of studies
After de-duplication, two review authors (IEW and AR or LH) independently screened titles
and abstracts to identify potentially relevant studies using Covidence [32], resolving discrepan-
cies through discussions and consultation of a third author. Two authors (IEW and AR or LH)
independently screened all full texts to identify eligible studies and one author (IEW) extracted
data on the participants, setting, phenomenon of interest and richness of data. Discrepancies
in eligibility and extracted data were discussed with a third author.
Once all studies which were eligible for inclusion were identified we used three purposeful
sampling techniques to select the studies for final inclusion and data extraction [33–35]. First,
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we used intensity sampling to select rich examples of the phenomenon of interest. We assessed
richness of included studies and classified studies accordingly as ‘thin’ or ‘thick’. ‘Thick’ was
defined according to the depth of analysis reflected in the primary study authors interpretation
of findings, including any of the following features: 1) the extent to which the authors trans-
formed/analyzed their findings (beyond lists of barriers and facilitators), 2) insight into par-
ticipants perspectives was demonstrated, 3) richness and complexity had been portrayed
(variation explained, meanings illuminated), and 4) theoretical or conceptual development.
Second, to ensure that all population groups were represented we expanded the sample by fur-
ther selecting eligible studies conducted in additional population groups of interest. Here we
included all additional studies—irrespective of whether they were ‘thick or thin’—conducted
in children and adolescents, pregnant women, key populations (sex-workers, people who
inject drugs, men who have sex with men) and vulnerable populations (people with disabilities,
refugees). Finally, we restricted our sample to studies conducted in Africa as it became evident
that our search yielded few ‘thick’ studies from other LMIC settings.
Data extraction and synthesis
Two authors (IEW and AR or LH) independently coded studies inductively, identifying new
codes using a grounded theory approach. We conducted In Vivo coding and generated
memos capturing emerging themes using Atlas.ti software [36]. We discussed the codes of
each study, resolved discrepancies and added new codes. We coded the authors results, discus-
sion and conclusions from the primary studies. We used thematic synthesis to identify themes
and subthemes. This was an iterative process through frequent weekly or biweekly small group
meetings (IEW, AR and LH), three intensive three day team sessions (IEW, AR, LH, and PG)
and monthly large group meetings (IEW, AR, LH, PG, and SO). We repeatedly refined our
conceptual model and codes according to the preliminary themes. We then re-evaluated the
remaining eligible studies and searched for confirming and disconfirming cases and selected
additional studies for data extraction [33]. Here we selected those studies that expanded on
existing themes, added illustrative examples, added data for new themes or contradicted exist-
ing themes. Essentially, further studies were included if they enriched our data further, either
by supporting previous findings where there was limited data, broadening our perspective of
preliminary findings or through introduction of new perspectives. We excluded studies where
no new information was introduced or there was no need for further supporting information
in our synthesis regarding the codes and themes identified in the primary study. Two authors
(IEW and AR) independently assessed these studies for inclusion, then proceeded with inde-
pendent coding of included studies and discussed each study to resolve discrepancies. The
additional data helped expand on and refine preliminary themes. This process was continued
until no new themes emerged and data saturation had been reached. The final codes used to
refine themes are presented in S3 Appendix. We adhered to the ENTREQ guideline for trans-
parency in reporting of synthesis of qualitative research (S4 Appendix).
Methodological quality assessment
We assessed quality of included studies using a modified version of the tool developed by the
EPPI-center [37] (S1 Table). Two authors (IEW and LH) independently assessed included
studies in terms of (1) rigor in sampling: the sampling strategy was appropriate to the ques-
tions posed in the study; attempts were made to obtain a diverse sample of the population in
question; characteristics of the sample critical to the understanding of the study context and
findings were presented, (2) rigor in data collection: data collection tools were piloted; data
collection was comprehensive, flexible and/or sensitive enough to provide a complete and/or
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vivid and rich description of people’s perspectives and experiences; steps were taken to ensure
that all participants were able and willing to contribute, (3) rigor in analysis: data analysis
methods were systematic; diversity in perspective was explored; the analysis was balanced in
the extent to which it was guided by preconceptions or by the data; the analysis sought to rule
out alternative explanations for findings, (4) findings of the study grounded in/ supported by
the data: enough data are presented to show how the authors arrived at their findings; the data
presented fit the interpretation/support claims about patterns in data; the data presented illu-
minate/illustrate the findings; quotes are numbered or otherwise identified, and (5) the
breadth and depth of study findings: (considering ‘breadth’ as the extent of description and
‘depth’ as the extent to which data has been transformed/analysed); a range of issues are cov-
ered; the perspectives of participants are fully explored in terms of breadth (contrast of two or
more perspectives) and depth (insight into a single perspective); richness and complexity has
been portrayed (e.g. variation explained, meanings illuminated); there has been theoretical/
conceptual development. These domains were assessed as: (1) Yes, a fairly thorough attempt
was made, (2) Yes, several steps were taken, (3) Yes, a few steps were taken, and (4) No, not at
all/Not stated/Can’t tell. Discrepancies were resolved through discussion or consultation of a
third author (PG or SO).
Reflexivity
The author team had a variety of research skills, which included both primary research and
evidence synthesis methods for quantitative and qualitative study designs. All had experience
working or conducting research in sub-Saharan Africa and fields of study were diverse includ-
ing medicine, HIV management (IEW), infectious diseases (PG), nursing and midwifery (AR),
and social science (LH and SO). Due to the subjective nature of qualitative synthesis we had
regular discussion meetings to reflect on personal biases or judgements throughout the process
of the synthesis. These discussions allowed us to reflect on emerging themes through different
perspectives and construct meaning in the current synthesis.
Results
Results of the search
Our search yielded a total of 11,518 records (Fig 1). After removal of duplicates, we screened
titles and abstracts of 5792 records and full texts of 397 articles. We excluded 136 full-text arti-
cles with reasons. Of the 261 eligible articles, 185 articles were not included in the sample as
they were either classified as ‘thin’ studies (n = 179), or were conducted in countries outside of
Africa (n = 6). We purposively sampled 76 articles and included 61 articles [38–99], reporting
on 59 studies, in the qualitative synthesis. The remaining 15 articles were not included in the
synthesis as data saturation was reached.
Studies included in the qualitative synthesis
A summary of the characteristics of studies included in the qualitative synthesis is presented in
Table 1. Of included studies 15 were conducted in South Africa, 9 in Uganda, 8 in Tanzania, 4
in Swaziland, 4 in Zimbabwe, 3 each in Ethiopia, Kenya, Malawi, and Zambia, and 1 each in
Cameroon, Lesotho, Mozambique, Nigeria, Rwanda, Kenya, Nigeria, and Tanzania. Studies
examined factors influencing linkage to care, adherence to ART or retention in care amongst
adults (n = 22), adolescents or children (n = 10), adults, adolescents and children (n = 2), men
(n = 4), women (n = 4), pregnant or postpartum women (n = 7), female sex workers (n = 3),
people who inject drugs (PWID) (n = 2), people living with disabilities (PWD) (n = 2), men
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who have sex with men (MSM) (n = 2) and refugees (n = 1). Studies used a variety of methods
to collect data, including in-depth interviews, focus-group discussions, ethnography, partici-
pant observation, role-play and photo-elicitation interviews, most studies used a combination
of methods. In-depth interviewing was the most common method of collecting data. Study
participants comprised HIV-positive as well as a few HIV negative people, caregivers of HIV-
positive children and adolescents, healthcare workers, traditional leaders, lay counsellors, com-
munity health workers and other key informants.
Fig 1. PRISMA flow diagram. a Sampled studies include those characterized as (1) conducted in Africa, and ‘thick’, or (2) ‘thin’ and belonging to specific population
group of interest: A ‘thick’ study was defined according to the depth of analysis which included the following features: 1) the extent to which the authors transformed/
analysed their findings, 2) insight into perspectives was demonstrated, 3) richness and complexity had been portrayed, and 4) there was theoretical or conceptual
development. “Thin” studies were all other studies not classified as ‘thick’. Specific population of interest studies included those classified as thin but that evaluated
perspectives which were of special interest for the review, including; provider perspectives, MSM populations, sex-worker populations; PWID populations; youth being
transferred to new facilities; or conducted among refugee populations. bData saturation was reached.
https://doi.org/10.1371/journal.pone.0210408.g001
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Table 1. Characteristics of included studies.
Study Country Phenomenon of interest Data collection methods Study participants
General adults
Appelbaum
Belisle 2015
South Africa Concurrent use of traditional African
medicine and ART
In-depth interviews and focus group
discussions
HIV positive adults, health workers, HIV
counsellors, traditional healers
n = 26
Asgary 2014 Ethiopia Beliefs about prevention, treatment,
alternative cures and role of spiritual
leaders in health education
In-depth interviews and focus group
discussions
Adults (positive and negative HIV status),
non-health personnel at health facilities,
school staff, health workers, medical
providers, community leaders
n = 52
Assefa 2014 Ethiopia Understanding interventions at
health facilities and community-
based organisations that improve
retention in care
In-depth interviews and focus group
discussions
Clinicians, adherence counsellors, case
managers, adherence supporters,
community-based service providers
n = 72
Axelsson 2015 Lesotho Adherence patterns, barriers to and
facilitators of adherence to ART
In-depth interviews HIV positive adults
n = 28Barfod 2013
Beckmann
2013
Tanzania Understanding how HIV-positive
people navigate life and the complex
treatment regimens
Ethnographic observations, in-depth
interviews
HIV positive adults
n = not reported
Bezabhe 2014 Ethiopia Barriers and facilitators to adherence In-depth interviews and focus group
discussions
HIV positive adults and healthcare workers
n = 58
Bhagwanjee
2013
South Africa Impact of gender roles and
relationships on HIV adherence
In-depth interviews Seroconcordant couples
n = 24
Bogart 2013 South Africa Barriers to linkage of care In-depth interviews and focus group
discussions
HIV positive adults and healthcare workers
n = 62
Braga 2013 Mozambique Experience of living with HIV and
interacting with health services
Ethnographic observations, in-depth
interviews
HIV positive adults, health workers, lay
counsellors, policy makers, traditional
healers, faith healers
n = 223
Campbell 2015 Zimbabwe Patient labelling as good or bad
patients and how it affects patient
experiences at clinic visits
Ethnographic observations, in-depth
interviews and focus group discussions
HIV positive adults, caregivers of children
with HIV, health workers
n = 104
Jones 2015 South Africa Treatment seeking behaviours of
HIV positive adults
Ethnographic observations and in-depth
interviews
HIV positive adults, health workers, lay
counsellors
n = 35
Katz 2015 South Africa Experiences linked to transfer of care
from PEPFAR funded clinic to state
funded clinics and the impact on
retention in care
In-depth interviews HIV positive adults
n = 36
Layer 2014 Tanzania Barriers and facilitators to linkage
and retention in care
In-depth interviews and participant
observation
HIV positive adults, health workers,
traditional healers, spiritual healers and lay
counsellors
n = 221
Layer 2014 Tanzania Experiences and factors influencing
decisions to disengage from HIV care
In-depth interviews HIV positive adults who had disengaged from
care
n = 14
Maeri 2016 Kenya Experiences and beliefs about HIV
disclosure among couples
In-depth interviews HIV positive and negative adults, health
workers, health managers, lay counsellors,
research assistants, community health
assistants and peer educators
n = 194
Masquillier
2015
South Africa Role and influence of household in
supporting adherence and retention
in care
In-depth interviews and focus group
discussions
HIV positive adults and community health
workers
n = 68
Naik 2013 South Africa Factors that influence linkage to HIV
care
In-depth interviews HIV positive adults
n = 30
(Continued)
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Table 1. (Continued)
Study Country Phenomenon of interest Data collection methods Study participants
Niehaus 2014 South Africa Factors other than treatment literacy,
that influence linkage and adherence
Ethnography, case study Life history of a man living with HIV/AIDS
n = 1
Okoror 2013 Nigeria Cultural context of HIV stigma on
adherence
In-depth interviews and focus group
discussions
HIV positive adults
n = 35
Rasmussen
2013
Uganda HIV counselling practices Participant observation and in-depth
interviews
HIV positive adults, lay counsellors
n = 12
Russell 2016 Uganda Influence of health care providers on
HIV self-management
In-depth interviews HIV positive adults on ART
n = 38
Russell 2016 Barriers and facilitators to HIV self-
management
Ware 2013 Nigeria Uganda
and Tanzania
Reasons for missed clinic visits and
disengagement from HIV care
In-depth interviews HIV positive adults who had disengaged from
care
n = 91
Adults and children/adolescents
Scott 2014 Zimbabwe Role of community networks in
facilitating access and adherence to
ART
In-depth interviews, focus group
discussions and participant observations
HIV positive adults, caregivers of HIV
positive children, health workers
n = 127
Inzaule 2016 Uganda Barriers and facilitators to long-term
adherence
In-depth interviews and focus group
discussions
HIV positive adults and adolescents in long-
term HIV care (expert clients), health
workers, lay counsellors
n = 33
Adolescents/children
Hornschuh
2014
South Africa Experience of HIV care amongst HIV
positive adolescents and young adults
Focus group discussions HIV positive adolescents and young adults
n = 18
Mburu 2014 Zambia Adolescents’ experiences with
disclosure
In-depth interviews and focus group
discussions
HIV positive adolescents, caregivers and
health workers
n = 170
Mutumba
2015
Uganda Challenges and coping strategies of
perinatally infected HIV positive
adolescents
In-depth interviews HIV positive adolescents
n = 38
Mutwa 2013 Rwanda Barriers and facilitators to adherence
in HIV positive adolescents
In-depth interviews, focus group
discussions and role play
HIV positive adolescents and their caregivers
n = 52
Wolf 2014 Kenya Reasons for disengagement in HIV
care among adolescents
In-depth interviews and focus group
discussions
HIV positive adolescents who had disengaged
from care, community health workers and
educators
n = 55
Busza 2014 Zimbabwe Barriers and facilitators of caregivers
of children with HIV to retention in
care
In-depth interviews Caregivers of children with HIV, key
informants from community-based support
services
n = 24
Kawuma 2014 Uganda Barriers to adherence during
childhood and adolescence
In-depth interviews HIV positive children and adolescents,
caregivers and health workers
n = 26
Mattes 2014 Tanzania Children and adolescents’
experiences of living with HIV
Participant observation, in-depth
interviews, thematic drawing and photo-
elicitation interviews
HIV positive children and adolescents,
caregivers
n = 24
Coetzee 2015 South Africa Barriers and facilitators to adherence
in HIV positive children
In-depth interviews and focus group
discussions
Caregivers of children with HIV, health
workers, HIV counsellors and traditional
healers
n = 42
Sikstrom 2014 Malawi Challenges to successful long-term
paediatric ART
In-depth interviews, participant
observation and in-depth case studies
HIV positive children and their caregivers,
key informants (religious leaders, health care
workers, grandparents, traditional healers,
farmers, landowners and self-employed
migrants)
n = 104
(Continued)
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Table 1. (Continued)
Study Country Phenomenon of interest Data collection methods Study participants
Men
Mburu 2014 Uganda Influence of stigma and masculinity
on engagement in HIV care
In-depth interviews and focus group
discussions
HIV positive men and women, household
members, health workers, health workers,
health managers, lay counsellors, community
leaders
n = 65
Sikweyiya 2014 South Africa The influence of HIV on the lives of
men and their sense of masculinity
In-depth interviews HIV positive men
n = 18
Siu 2013 Uganda Men’s construction of masculinity
and its influence on HIV treatment
seeking behaviour
In-depth interviews and participant
observation
HIV positive and negative men
n = 26
Siu 2014 Influence of HIV on gender relations
and men’s sense of masculinity
Zissette 2016 South Africa Influence of masculinity on access to
and utilisation of HIV care
In-depth interviews and participant
observation
HIV positive men
n = 21
Women
Dlamini-
Simelane 2016
Swaziland Factors influencing access to care
amongst married women with HIV
Ethnographic observations and in-depth
interviews
Married women with HIV
n = 2
Mbonye 2016 Uganda Perceptions related to early linkage
(test and treat)
In-depth interviews HIV positive and negative women
n = 15
Watt 2017 South Africa Impact of sexual trauma on HIV care In-depth interviews HIV positive women with sexual trauma
histories
n = 15
Wouters 2016 South Africa Women’s experience of living with
HIV and accessing care
In-depth interviews HIV positive women
n = 12
Pregnant/postpartum women
Elwell 2016 Malawi Factors influencing retention in
Prevention of Mother to Child
Transmission (PMTCT) programmes
In-depth interviews, focus group
discussions and participant observations
HIV positive pregnant or postpartum
women, health workers, community leaders
n = 95
Gourlay 2014 Tanzania Influence of patient-provider
interactions on PMTCT uptake
Participatory learning and action group
activities (includes focus group discussions,
role-playing, creating maps), in-depth
interviews, participant observation
HIV positive and negative women and men,
health workers and health officials
n = 91
Hatcher 2016 South Africa Influence of intimate partner
violence (IPV) on PMTCT uptake
and adherence
In-depth interviews HIV positive women experiencing IPV
n = 32
Katirayi 2016 Swaziland Barriers and facilitators to linkage
and adherence of Option B+
In-depth interviews and focus group
discussions
HIV positive pregnant or postpartum women
and health workers
n = 132
Kim 2016 Malawi Barriers and facilitators to linkage
and adherence of Option B+
In-depth interviews HIV positive pregnant or postpartum women
n = 65
McMahon
2016
Tanzania Factors influencing disengagement
from PMTCT care
In-depth interviews HIV positive pregnant or postpartum women
who had disengaged from HIV care
n = 40
Ngarina 2013 Tanzania Barriers to adherence post delivery In-depth interviews HIV positive women with detectable viral
load after 24 months of delivery
n = 23
Female sex workers
Fielding-Miller
2014
Swaziland Experience and health service needs
of sex workers
In-depth interviews HIV positive sex workers
n = 20
Mtetwa 2013 Zimbabwe Barriers to linkage and retention in
care among sex-workers
Focus group discussions HIV positive sex workers
n = 38
(Continued)
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Quality
Critical appraisal of the 61 included papers demonstrated that the studies were of high quality
with the majority making a ‘fairly thorough attempt’ at increasing rigor in sampling (57; 93%)
and data collection (52; 85%), and grounding the findings in the data (54; 88%). Studies scored
less well on ‘rigor in analysis’, and the ‘breadth and depth of their findings’, with 41 (67%) and
40 (66%) being assessed as having made a ‘fairly thorough attempt’ respectively. This lower
score for some studies was mostly due to poor reporting of analysis techniques and a lack of
transformation of the data beyond lists of the main themes. Critical appraisal findings are pre-
sented in S2 Table.
Context specific sub-themes and codes
Codes and themes emerged from a variety of settings repeatedly and reflected commonalities
across population groups. There were however a few codes and sub-themes which were unique
to particular settings. For example, the use of holy-water as an alternative or adjunctive treat-
ment for HIV was described in studies from Ethiopia, the provision of a financial ‘disability
grants’ to HIV-positive people was uniquely described in South Africa, and issues related to
adolescents and children in boarding school settings emerged predominantly from East Africa
(Uganda, Kenya, Rwanda and Zimbabwe). Challenges pertaining to same day ART initiation
were primarily described by women in antenatal services. There were very few examples of
Table 1. (Continued)
Study Country Phenomenon of interest Data collection methods Study participants
Nakanwagi
2016
Uganda Facilitators and barriers to linkage to
HIV care among female sex workers
In-depth interviews HIV positive sex workers, peer educators,
NGO outreach workers
n = 44
People who inject drugs (PWID)
Guise 2016 Kenya Barriers and facilitators to HIV care
amongst People who inject drugs
(PWID)
Ethnographic observations and in-depth
interviews
HIV positive people who inject drugs
n = 118
Saleem 2016 Tanzania Barriers and facilitators to linkage to
care among people who inject drugs
In-depth interviews HIV positive people who inject drugs
attending a methadone clinic, health care
providers
n = 32
People living with disabilities
Parsons 2015 Zambia Experiences of HIV positive adults
with disabilities and how this
influences access to HIV care
In-depth interviews HIV positive adults with disabilities
n = 32
Yoshida 2014 Zambia Experience of HIV positive people
with disabilities
In-depth interviews HIV positive adults with disabilities
n = 21
Men who have sex with men (MSM)
Cange 2015 Cameroon Influence of stigma on men who have
sex with men (MSM) mental health
and access to HIV care
In-depth interviews and focus group
discussions
MSM (regardless of HIV status)
n = 310
Kennedy 2013 Swaziland Experiences and health needs of HIV
positive MSM
In-depth interviews and focus group
discussions
HIV positive MSM, HIV programme
planners, policy makers, health workers,
community leaders
n = 62
Refugees
Mendelsohn
2014
Kenya and
Malaysia
Factors influencing adherence and
retention in care amongst refugees
In-depth interviews HIV positive refugees
n = 26
https://doi.org/10.1371/journal.pone.0210408.t001
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these context specific themes as most findings emerged from several African settings and this
is highlighted in the supporting evidence (S1–S9 Evidence Annexes).
Themes
We identified nine themes and grouped these into three main areas: (1) HIV-positive people
navigate a complicated world, (2) the health system is punishing and uninviting, and (3) adapt-
ing and incorporating ART into life (Table 2).
Theme 1: Poverty, competing priorities and an unpredictable microworld (S1 Evidence
Annex)
The lives of those who live in poverty and are HIV-positive contain many short and long-
term competing priorities, complicated by frequent personal life events and external
disruptions.
Poverty and the need to prioritize: Poverty creates economic pressures which forces many
HIV-positive people in Africa to make difficult choices daily. People may choose to earn an
income [41, 46, 48, 62, 80, 81, 97, 100–104], address food insecurity [41, 51, 65, 70, 75, 81, 86,
105], or personal safety [50, 57, 68, 100] over sorting out long-term HIV treatment; and the
cost in terms of time and money of getting to services, creates a further obstacle [46, 48, 80,
102]. Survival for some requires them to remain socially connected, and as a result HIV-posi-
tive people, particularly women, may choose to maintain their social network rather than take
ART, especially if HIV disclosure will compromise economic support systems [43, 51, 62, 68,
69, 81, 94, 100, 103, 106–108].
Unpredictable life events: Life events regularly disrupt routines; intermittent and unpredict-
able changes in family responsibilities [41, 94, 100], or the sudden onset of refugee status [75]
can lead to a reprioritization of immediate needs. Further disruptions such as loss of support
systems [75, 90] or unexpected problems with travel in highly mobile populations [57, 59, 81,
94, 100, 104] create structural obstacles to attending health services and contribute to gaps in
ART care.
Theme 2: Social identity and gender norms can have a profound impact on care-seeking
behavior (S2 Evidence Annex)
Social identity influences how HIV-positive people respond to HIV and ART. When indi-
viduals do not fulfil their societal defined roles, they may be judged harshly and ostracized.
Many HIV-positive people strive to avoid discrimination and maintain their social identity,
and this is sometimes at odds with initiating or continuing ART.
Gender roles impact health care decisions: Women have socially defined roles which often
revolve around reproduction and caring for the family [85, 97, 108]. Competing maternal and
marital responsibilities make it difficult for them to put their health first [54, 97, 109]. Poor
Table 2. The nine emergent themes.
HIV-positive people navigate a complicated world
1: Poverty, competing priorities and an unpredictable microworld
2: Social identity and gender norms can have a profound impact on care-seeking behavior
3: Alienation makes it hard to take ART
4: People with HIV receive conflicting information, messages and views
The health system is punishing and uninviting
5: “Bad patients” are an unhelpful construct of an authoritarian health system
6: Poor clinic services for patients and inadequate support for health workers
It is difficult to adapt to and incorporate ART into life
7: The new normal requires daily drugs
8: Self-efficacy, social responsibility and support helps
9: The tipping point
https://doi.org/10.1371/journal.pone.0210408.t002
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women are often economically dependent on their partners and frequently disempowered in
the household: they may not be able to make health care decisions on their own [61, 65, 107,
108], and are vulnerable to discrimination and abuse [54, 57, 65, 68, 69, 78, 100, 107–110].
HIV disclosure [81, 108] and infertility [85, 97, 108] may put women at risk of discrimination,
social isolation and put them and their children’s survival at risk. To maintain their physical
and economic safety, women carefully negotiate personal relationships and social networks in
order to care for their children and themselves [57, 81, 103, 107].
Many men try to fulfill hegemonic representations of masculinity and want to be: strong
and powerful [73, 92, 93], respected in society [73, 86, 91–93, 99], and father children [91, 99],
work and provide economically for their families [73, 86, 89, 91, 92, 99]. This was hard after
HIV diagnosis, as many men struggled with loss of power and respect in society, and at home
[73, 91–93]. Attending HIV services requires both the acceptance of a weakened state and
entry into traditionally female spaces [73, 91, 92, 99]. As a result, the requirements of long-
term HIV care may be at odds with maintaining masculine identity and many men only seek
care when a marked clinical deterioration is apparent [73, 91, 92, 99].
It is confusing and isolating being a child or adolescent with HIV: Children and adolescents
with HIV desperately want to ‘fit in’ with their peer group [77, 78, 111]; adolescents want to
plan for their future[70], have sexual relationships [70, 77], and they struggle to navigate all of
this in the context of being HIV-positive. Some respond with anger and rebellion [78, 111];
others become isolated, secretive and depressed [77, 78, 111]. They remain dependent on
adults for care and supervision and need stable home and school environments to thrive [59,
77, 78, 90]. Despite these needs, the support systems for HIV infected children and adolescents
are often fragmented and change frequently [51, 78, 90]. Paediatric drug formulations for
young children may not be palatable, and drug side-effects [51, 70], and lack of privacy for
adolescents [51, 58, 59, 77, 78, 96, 111] makes adhering to ART particularly difficult. This is all
compounded by adults not knowing how to deal with children who are HIV-positive. Caregiv-
ers may delay disclosure of HIV status, due to guilt about their own HIV-status, concerns
about children’s cognitive abilities and social norms regarding discussion of sexuality with
children [59, 72]. Health care workers often do not communicate directly or appropriately
with children [51, 70, 72, 96], and this is exacerbated when children are transferred to non-
paediatric adult or general HIV services [58, 59]. Poor communication creates confusion
about HIV and ART, and when combined with fear of rejection and secrecy, depression and
incoordinate support systems can markedly compromise adherence in this group [59, 70, 111].
Lack of conformity leads to double stigma for HIV-positive key populations: HIV-positive
key populations face marked discrimination related to their life-style. MSM, PWID and sex-
workers all do not conform to social norms and as a result are morally judged and discrimi-
nated against by others [50, 54, 64, 80, 88]. This discrimination is often worse than that experi-
enced by those who are HIV-positive alone [50, 54, 64] and may cause psychological distress
[50, 64], compounded by criminalization of MSM and sex-work in several African settings
[50, 54, 88]. As a result, key-populations often have very limited support [50, 64, 76, 88] and
for PWID, even with excellent support, drug addiction may trump any consideration of health
status [56]. Discrimination plays a large role in keeping key populations away from general
HIV services [64, 76, 88].
HIV-positive people with disabilities (PWD) defy social expectations: Society often assumes
people with disabilities are asexual, and sub-human, and as a result HIV-positive PWD
describe being discriminated against on many levels [84, 112]. This and structural obstacles to
accessing care, may cause some to disengage [84].
Theme 3: Alienation makes it hard to take ART (S3 Evidence Annex)
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Stigma alienates HIV-positive people from their social group and reduces their motivation
to take ART. Fear of the consequences of HIV disclosure further impacts adherence and
engagement in care.
HIV stigma and discrimination, makes it hard to take ART: HIV is associated with sexual
promiscuity, being infectious and close to death [46, 67, 77, 78, 81, 84, 103]. People judge HIV-
positive people morally and fear HIV transmission resulting in discrimination by partners,
family and friends, employers, educators, and the general community [46, 59, 70, 72, 77, 83,
84, 111]. After disclosure of HIV status people may lose their emotional and financial support
systems [39, 67–69, 83, 91, 103, 108]. In addition, some feel ashamed of their HIV status,
blame themselves for becoming infected and internalize stigma [46, 67, 73, 83, 84, 103]. Dis-
crimination and internalized stigma can make people feel isolated, hopeless and depressed [39,
46, 64, 67, 83]. It is hard for HIV-positive people to maintain adherence and engage in HIV
care when they feel sad, alone and unsupported [46, 81, 100, 103]. Due to the anticipated nega-
tive consequences of disclosure people will go to great lengths to keep their HIV status secret,
this secrecy makes it difficult to take ART regularly and attend HIV clinic services [46, 48, 53,
68, 79, 83, 94, 104], particularly if disclosure has not occurred in the household [48, 57, 65, 68,
69, 77, 78, 81, 91, 96]. Exposure at HIV clinics creates further challenges in maintaining confi-
dentiality, and if the clinic location, design or staff compromise this, HIV-positive people will
disengage from care [46, 47, 53, 56, 67, 74, 79].
Theme 4: People with HIV receive conflicting information, messages and views (S4 Evi-
dence Annex)
Competing ideologies, HIV treatment options and experiences, combined with frequently
changing HIV guidelines can create uncertainty about initiating or maintaining ART.
Alternative discourses about HIV and ART: There are many alternative discourses, beliefs
and sources of information about the causes and treatment of HIV [38, 39, 43, 67, 74, 79, 80,
82, 91, 104, 105]. People’s beliefs may be informed by religious leaders, politicians, traditional
healers, mass media, community members, friends and family [39, 67, 80, 82]. All of these
influences can facilitate or hinder engagement. Religious and spiritual healers can sometimes
offer better explanations and treatments, especially if those belief systems are well established
and trusted by communities [38, 67, 79, 80, 91]. Ideologies which offer a cure are particularly
appealing to HIV-positive people [39, 67, 74, 91, 104].
Side-effects undermine the message of improved health on ART: Drug side-effects and
deterioration on treatment creates doubt regarding the health benefits of ART, and those who
feel well when they initiate treatment may as a consequence disengage from care [65, 74, 87,
104]. Fear of such a deterioration prevents others from linking to care in the first place [47,
80].
Scientific uncertainty confuses patients and reduces confidence in the biomedical health
system: Frequent changes to ART guidelines such as reduced CD4 thresholds for treatment
initiation and guidance on risks of transmission between couples on ART can confuse patients
and reduce confidence the biomedical health system [43, 61, 71, 82].
Choosing an ideology and treatment: People navigate through all the information, their
experiences and those of others, weigh up the options and choose the ideologies which fit their
needs best at a particular time [43, 82].
Theme 5: “Bad patients” are an unhelpful construct of an authoritarian health system (S5
Evidence Annex)
The authoritarian biomedical health system expects HIV-positive people to adhere to ART.
Those who are able to comply are treated well, but when they fail to adhere they may be pun-
ished and disrespected.
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Authoritarian health system: The biomedical health system and HIV care is delivered
within an authoritarian and paternalistic health system [49, 55, 85]. Health workers control
people’s clinic experience, decide who will get ART, and set the rules which HIV-positive peo-
ple are expected to live by [43, 47, 49, 85, 94]. This power imbalance creates a situation where
HIV-positive people work hard to carry favor with health workers [43, 49, 55, 85, 87] and
some health workers are disrespectful to HIV-positive people [46, 47, 67, 94] because they
have few other options for care.
Rules and responsibility: HIV-positive people are expected to follow an explicit set of rules
in the form of ART and lifestyle—‘positive living’–guidelines [41, 45, 47, 49, 53, 54, 60, 82, 85,
87, 90, 92, 104]. They are advised; to adhere to clinic appointments and the ART treatment
schedule; to obey clinic rules [41, 49, 85, 87]; to understand HIV medical terms [47, 60, 82, 87];
to stop drinking alcohol; to reduce sex [82, 85, 87, 93]; to avoid pregnancy [53, 85, 87]; to eat
‘healthy foods’ [44, 45, 54, 87, 90, 104]; to reduce ‘stress’ [43, 77, 87, 97]; to embrace their HIV-
positive identity; and to help other HIV-positive people [43, 87]. Staff expect individuals to
adhere to these rules [43, 46, 47, 82, 85] and often ignore how the realities of people’s lives may
interfere with the ability to be compliant [43, 53, 85, 87, 90]. For some, this rules-based system
works well [45, 55, 86, 87, 91], they adhere and they gain self-confidence [86, 91]; but others
who cannot adhere, feel stressed, ashamed, and guilty [43, 60, 66, 94]; and are then labelled
‘drop-outs’, ‘defaulters’ or ‘bad patients’ [47, 49, 96], justifying mistreatment by health workers,
who at times see this ‘failure’ as a personal characteristic, and morally judge, blame and inflict
punishment [47, 94, 96]. This can drive those who are already struggling to maintain atten-
dance to disengage from care entirely [43, 47, 49, 66, 67, 92, 94].
Theme 6: It is difficult and stressful attending public ART clinics (S6 Evidence Annex)
It is difficult, stressful and often unpleasant attending HIV services in the public sector;
partly mirrored in health worker reflections of an overburdened and under-resourced service.
It is difficult and stressful attending public ART health services: The experience of attending
HIV health services can be unpleasant. HIV-positive people may have to deal with rude health
workers who disrespect and humiliate them [46, 47, 49, 53, 55, 62, 64, 66, 67, 92, 94, 104],
inflexible and unaccommodating services with rigid policies [67, 94], long waiting times [41,
46, 48, 56, 62, 74, 79, 104] and unrealistic requirements [60, 80, 88], at times having to navigate
confusing systems and unpredictable visits, where they cannot be sure they will receive the
care they came for [46, 47, 49, 67]. For some, such services are unacceptable and they disen-
gage from care [47, 49, 67, 79, 94].
It is hard work being a health care worker: Health care workers describe being over-bur-
dened with excessive work-loads due to staff shortages and limited resources [53, 67, 88, 104],
having inadequate support and training, and limited skills to deal with the weight of the social
problems which they are presented with [67, 85]. They also describe feeling pressured to pro-
duce good treatment outcomes to feed back to program funders and managers [47, 85].
Theme 7: The new normal requires daily drugs (S7 Evidence Annex)
Accepting HIV and ART is not easy, it is influenced by perceived risk, time, health status,
and belief in the biomedical rationale. Incorporating HIV and ART into a new version of life
and identity, helps some adhere and engage in the long term.
Accepting HIV is difficult: Accepting HIV is hard and influenced by an individual’s percep-
tion of their own risk for infection prior to testing [79, 97]. A HIV-positive diagnosis is often
met with shock [61, 65, 67, 74, 79, 97, 110], and many, at first, deny results and seek out repeat
confirmatory tests at different health facilities [46, 61, 69, 74, 79, 80]. People struggle to recon-
cile how their lives, relationships and reproductive desires may have to change as a result of
being HIV-positive [91, 97]. Some have maladaptive responses, feel hopeless and depressed
[79–81, 91], or turn to substance abuse to cope [79, 91]. Over time, however, many accept the
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diagnosis and start to consider attending HIV services and initiation of ART [60, 69, 74, 79,
80, 88, 95].
Time and health status can influence the decision to initiate or maintain ART: The lack of
time to prepare for ART is a particular challenge for those offered ART on same day as diagno-
sis, particularly if they feel well at the time [61, 65, 71, 74, 81]. Those who are healthy when
they test HIV-positive or initiate ART are often poorly motivated to link to care or maintain
ART [60, 61, 67, 71, 74, 79, 81, 88]; but those who have experienced a decline in health due to
HIV and recovered on ART, feel highly motivated, at least initially, to engage in care [65, 67,
70, 73, 78, 83, 93, 104]. Once health is restored, people want to re-integrate into social life and
feel normal, and taking ART sometimes impairs the ability to do so, as daily medication and
clinic attendance interferes with the sense of leading a ‘normal’ life [43, 78, 85].
Accepting the medicalization of life: Over time many HIV-positive people learn to accept
the medicalization of their lives [60, 61, 87, 97] and make several lifestyle changes to adapt to
ART [47, 71, 83, 91, 93]. This is not always easy and can result in selective adherence to some
rules and adaptation of others [41, 86, 87]. For some accepting the biomedical rationale and
feeling like they can take control HIV by adhering to ART guidelines helps [86, 97, 99], this is
however not essential and several people maintain alternative beliefs about HIV, and still
adhere to ART [39, 65, 67, 78, 82, 91]. Some manage to incorporate HIV and ART into a new
hybrid identity allowing them to feel like they can live a ‘normal’ life, with HIV [40, 79, 86, 91,
93, 97]. There are a few select HIV-positive people who fully embrace their HIV status and cre-
ate an advocate identity which is defined by being HIV-positive [43, 98, 99]. But even among
those who accept HIV and ART, many still harbor a deep desire to be rid of the disease and
hope for a cure [43, 70, 75, 97].
Theme 8: Personal motivation and support helps (S8 Evidence Annex)
Inherent self-efficacy and a desire to fulfill social responsibilities help HIV-positive people
feel motivated to take ART, and emotional, practical or financial support helps them feel
accepted, cope with challenges, and adhere to ART.
Self-efficacy varies: How HIV-positive people respond to an HIV diagnosis and life-long
treatment is variable, with individuals demonstrating different self-management abilities (self-
efficacy) and thresholds for disengagement [57, 79, 86]. Some, despite substantial challenges
maintain adherence, and others are driven out of care by what appear to be smaller obstacles
[57, 79, 86].
Having others to care for is a motivator: Although it is difficult for people to accept HIV
and ART, having a family [57, 80, 89, 92, 99, 104] or an unborn child to protect and care for
[53, 57, 61, 65, 69] can motivate HIV positive people to take ART.
Support helps: Social support helps HIV-positive people gain self-confidence and a sense of
belonging and offsets the effects of stigma [86, 88, 89, 91]. Partners, friends, family members
and others can facilitate HIV acceptance and motivation to take ART [41, 48, 68, 79, 86, 88, 96,
99]. Spirituality, religion and allopathic medicine practitioners also provide support, especially
in settings where these practices and belief systems are firmly established [38, 67, 70, 77, 86].
HIV specific health services and peer groups can create a nurturing environment where HIV-
positive people can meet, support each other and foster a sense of belonging [41, 67, 80, 86,
89]. HIV counselors offer messages of hope after diagnosis and try to help reframe HIV as a
normal chronic disease for those struggling to accept their HIV-positive status [55, 79, 80, 86–
88, 97]. Mutually respectful long-term relationships with health care providers are features of
health services where patients feel supported [68, 86, 89]. Community organizations, commu-
nity health workers and home based carers play a variety of roles in the community including
providing palliative care to the very sick and encouragement to return to care for those who
have disengaged [40, 65, 67, 89]. Provision of financial and food aid can help alleviate some of
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the struggles of poverty and allow patients to focus on their health, but in settings of severe
poverty, dependence on such aid programs can have negative effects on compliance if aid is
withdrawn or based on health status [60, 69, 89, 92, 104]. Overall, emotional, practical and
financial support, for the most part plays a large role in helping HIV-positive people accept
HIV and adhere to ART [45, 48, 64, 80, 88, 104].
Theme 9: The tipping point (S9 Evidence Annex)
Several influences interact and drive people in or out of care, with the final driver at times
ascribed to disrespectful health workers or a deterioration in health.
Interacting factors and final events: There is a complex interplay between the individual,
their environment, the health system, and time. These elements work together to influence
engagement and adherence decisions [67, 74, 81, 94]. For example, disengagement for some,
starts with one unexpected absence from care which when followed by various other obstacles
leads to sustained disengagement [65–67, 94], and in a few instances a tipping point is
described, where a sequence of events culminates in a final episode which drives HIV-positive
people out of care, most often related to poor clinic services and disrespectful health workers
[60, 65–67, 79, 94]. A similar final event or ‘tipping point’ is also described by some who return
to care after an absence or link for the first time, and this decision to engage in care is fre-
quently the result of a deterioration in health [59, 65, 67, 69, 74].
Conceptual model
Based on these themes we developed a theoretical model demonstrating how multiple influ-
ences may act on an individual over time and result in changes in engagement and adherence
behavior (Fig 2). The model demonstrates how several external influences -representing the
effects of politics, society, and health systems—work to drive engagement and adherence
behavior. This includes the negative effects of: living in poverty, where multiple competing pri-
orities are constantly weighed up to ensure survival, and frequent unpredictable live events
interfere with routines; social and gender norms may impair the ability to incorporate HIV
and ART into daily life; and various sources and discourses about HIV and ART may confuse
patients. We also highlight that the quality of clinic services can drive patients in or out of care,
and that authoritarian rules-based health provision has a bidirectional effect, which may be
valued by some patients but disliked by others who prefer to be partners in health care deci-
sions. Logistic, emotional or final support from others: in the household, community, or at the
health center, helps patients cope with challenges of taking ART and for the most part act as a
positive external influence on engagement in care and adherence. The model further depicts
how personal motivators also play a large role in determining treatment and care behavior:
with high levels of self-efficacy and acceptance of the HIV diagnosis resulting in better adher-
ence and engagement, and the desire to restore or maintain health for those who have been
clinically ill acting as a motivator for many. Additionally, a sense of responsibility to care for
and support family members, helps some remain in care and on treatment. Finally, we demon-
strate how any combination of external influences and personal motivations may act together
to tip patients in or out of care or change levels of adherence, and how HIV positive people
may cycle in and out of these states over time. This theoretical model supports the ecological
perspective of health behavior [113] and additionally represents how engagement is a dynamic
process which fluctuates over the long course of HIV care.
Discussion
This synthesis, across multiple African populations, revealed common patterns of how HIV-
positive people make engagement and adherence decisions.
Being HIV positive and staying on antiretroviral therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0210408 January 10, 2019 16 / 30
Being HIV positive and staying on antiretroviral therapy
PLOS ONE | https://doi.org/10.1371/journal.pone.0210408 January 10, 2019 17 / 30
First, HIV-positive people constantly navigate a complex environment with numerous
influences and barriers to accessing care. It was evident that living in poverty prevented many
from being able to attend to their health needs either due to other priorities or disruptions,
reflecting the pervasive problem of reduced access to health care for those who are poor [114].
It was however described that some of these challenges could be overcome with help from oth-
ers, but that an HIV diagnosis often compromised support systems. It is well described that
belonging to strong familial and extrafamilial social networks can ameliorate some of the diffi-
culties of living in poverty, and that social networks provide social capital which can be drawn
on during difficult times [115–117]. HIV-positive people also struggled to accept how their
personal and social identity changed with HIV, a challenge faced by many who develop
chronic illnesses [118], but made more difficult in the face of HIV-related stigma. HIV stigma
posed a major threat to preserving social identity, with some choosing their social world and
support networks over ART. The profound negative impact of stigma on ART adherence and
engagement has been identified in Africa and other settings since early in the HIV epidemic,
Devine and colleagues described in the 1990’s how ‘AIDS’ stigma specifically went beyond
people’s fears of being infected and reflected a deeper ‘socially constructed phenomenon’
related to social identity and prejudice—it was seen as a ‘threat to core social values’ [119],
findings which remain relevant in the current era [21, 25] and are mirrored in accounts of
moral judgements and assumptions about sexual behavior in our synthesis. The descriptions
of how stigma impaired HIV care seeking were particularly vivid among marginalized and vul-
nerable groups due to the intersectionality between various forms of stigma [120]. This was
apparent among key populations experiences of ‘double stigma’ related to HIV and lifestyle,
and women’s experiences of marked social and economic isolation following HIV disclosure.
In addition to these substantial barriers to care seeking, alternative discourses about the causes
and treatment of HIV frequently resulted in delayed engagement or disruptions in care. The
influence of this medical pluralism on HIV care seeking in Africa cannot be underestimated,
and in a recent large multi-country qualitative study, Moshabela and colleagues demonstrate
how HIV-positive people ‘shop and switch’ between biomedical, traditional and faith based
health care systems and how this leads to bottlenecks along the HIV care cascade if people use
this as alternative rather than complementary care [121]. This contributed to people’s overall
uncertainty about HIV care, which was in our exploration compounded by frequently chang-
ing HIV guidelines and drug side-effects which undermined overall confidence in ART and
the biomedical health system.
Second, challenges faced when attending health services can drive HIV-positive people out
of care. Accounts of authoritarian health systems, overburdened health workers, disrespectful
staff and difficult clinic visits have been reported across health services in Africa and are not
unique to HIV care [122–125], however the moral judgment and labelling of poorly adherent
patients was an additional aspect which made it difficult for some to remain or return to care.
Third, individual characteristics, time and support systems influence the response to a HIV
diagnosis and the ability to maintain long-term adherence and engagement in care. Accep-
tance of HIV can take time [126] and it appears that the trajectory of becoming an adherent
self-managing HIV-positive person follows a similar course to the processes of coping with
other chronic illnesses, with people transitioning through several stages, including: learning
about the condition, modifying lifestyle, activating psychological, spiritual and social
resources, and finally learning to live with HIV and make meaning of it [127, 128]. In our data
Fig 2. Theoretical model of influences on engagement and adherence to ART.
https://doi.org/10.1371/journal.pone.0210408.g002
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this process was positively influenced by strong support systems, previous HIV related illnesses
and the desire to stay alive to care for dependents.
Finally, even for those who accepted HIV and adapted to ART, the numerous influences
fluctuated and changed over time causing people to transition in and out of care, a pattern
which has also been identified in HIV cohort data from high income settings [129].
This review goes beyond presenting barriers and facilitators and describes broadly how var-
ious external influences and personal motivation interact and drive ART adherence and
engagement decisions, and presents a model for understanding ‘why people do what they do’.
Our findings are strengthened by a detailed, rigorous and iterative process of data-extraction
and synthesis involving the entire author team and a large body of supporting evidence pre-
sented in this paper and supplementary materials. We included primary studies from across
the African continent and did not identify any major themes which occurred exclusively in
any one setting, making these finding generalizable to HIV-positive people across Africa.
Although there were no studies conducted in prisoners and transgender people which contrib-
uted to our synthesis, we believe that some of our findings regarding experiences of marginal-
ized groups may translate to some extent to these populations, it is possible however that some
of their unique challenges are missing from this review. There were few studies identified
which provided the perspectives of health workers suggesting that the experiences of health
workers deserve further research.
We believe this analysis can help provide a springboard at a national or local level for
thoughtful decision making in policy, and for providers, government, non-governmental orga-
nizations, and advocacy groups to generate approaches at various levels and create long term
solutions. Given the numerous primary studies identified in this review we suggest that
researchers intending to conduct more qualitative studies in this field consider what may be
different—in light of these findings, and what additional information may be needed to help
inform the health policy decisions in their setting.
Our review search was conducted on 9 December 2016 and it is possible that some of the
landscape regarding stigma and access to care may have changed in the ‘test and treat’ and dif-
ferentiated service delivery era. However, after conducting an updated search and rapidly
appraising recently published studies (up till 1 August 2018), we identified several studies
which supported our findings, specifically regarding quality of health services [130–133], disre-
spectful health workers and the role of power in health service delivery [132, 134], lack of
access to health services [130, 131], competing priorities and unpredictable life circumstances
[135–138], the role of the social world [131, 132, 139], influence of gender roles [140], medical
pluralism [132, 141], the motivating influence of having dependents [142, 143], the challenges
of same day ART initiation[144], the barriers to care caused by stigma [130, 131, 138, 143, 145,
146], challenges to accessing care for PWD [147], the benefits of support [131, 132, 148, 149],
and fluctuations in engagement over time [131]. We therefore feel that the findings of this
review remain relevant to current HIV populations.
Conclusions
This analysis broadly reflects what HIV-positive people grapple with on a day-to-day basis as
they try to manage a highly stigmatized chronic life-threatening illness within the context of
every-day life in Africa. Many of the barriers we identified, have previously been well-articu-
lated and are obvious; and there are many systematic reviews of trials of technical fixes to
assure adherence. What this review offers is a new theoretical model of the dynamics of adher-
ence and engagement in care that can help providers understand their patients, their dilem-
mas, and how this plays out in real time in order to help with the design of service delivery
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approaches sensitive to what is happening in people’s lives. The themes and theory generated
provide a basis for more informed thinking and action on the part of policy makers, providers,
and society to understand what influences HIV-positive people in Africa, and how the atti-
tudes and culture of societies and the health service needs to shift to help those with HIV to
successfully lead more normal lives.
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